SF4, also known as Splicing Factor 4, is a protein that plays a critical role in the process of pre-mRNA splicing, an essential step in gene expression in eukaryotic cells. This process involves the removal of non-coding sequences (introns) from pre-messenger RNA (pre-mRNA) and the joining of the coding sequences (exons), leading to the formation of mature messenger RNA (mRNA) that can be translated into proteins.As a splicing factor, SF4 is part of a larger complex of proteins and RNA molecules known as the spliceosome. The spliceosome is responsible for recognizing and accurately removing introns from pre-mRNA. SF4 contributes to the assembly and stabilization of this complex, ensuring the precise and efficient splicing of pre-mRNA.
The precise regulation of splicing is crucial for the generation of protein diversity and the proper functioning of cells. Alternative splicing, where the same pre-mRNA is spliced in different ways to produce multiple mRNA variants, is a key mechanism for expanding protein diversity. SF4, by participating in the splicing process, indirectly influences this diversity.Mutations or dysregulation in splicing factors like SF4 can lead to aberrant splicing, which has been implicated in various diseases, including cancer and genetic disorders. Understanding the role and mechanism of splicing factors is therefore essential in understanding the molecular basis of these diseases.SF4, like other splicing factors, is also a subject of interest in research. Modulating the activity of splicing factors could correct aberrant splicing patterns in diseases, offering a novel avenue for intervention
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Pladienolide B is a spliceosome inhibitor, potentially impacting SUGP1-involved pathways by altering splicing dynamics. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
This compound inhibits the spliceosome, potentially impacting pathways where SUGP1 is involved. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor, Isoginkgetin may indirectly affect SUGP1's role in mRNA splicing. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Herboxidiene, a spliceosome inhibitor, might influence SUGP1-related pathways by affecting splicing. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
As a splicing inhibitor, Madrasin could indirectly affect the function of SUGP1 in spliceosomal processes. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
This compound inhibits the spliceosome, potentially impacting SUGP1-associated pathways. | ||||||
Tetrabenazine | 58-46-8 | sc-204338 sc-204338A | 10 mg 50 mg | $165.00 $707.00 | ||
Thiabendazole (TBZ), an antifungal and spliceosome inhibitor, may affect SUGP1 indirectly. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
An inhibitor of eukaryotic initiation factor 4A (eIF4A), Silvestrol could influence SUGP1 through translational regulation. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
This alkaloid inhibits protein synthesis and might indirectly affect SUGP1 function. |